Merger: absorbed by Kemphanen
Dissolution of the company · Dissolved without liquidation · General meeting of 31-05-2021 · Gazette deed
Merger proposal: to be absorbed by KemphanenName hiddenVisible after signing in and Hidden nameVisible after signing in act as permanent representatives · Gazette deed
Name after signing inVisible after signing in reappointed as directorName hiddenVisible after signing in acts as permanent representative · General meeting of 27-04-2019 · Gazette deed
Demerger: Duyts-Moriaux splits off to DUMOVEN
Company renamed to MARKTAPOTHEEK · Hidden nameVisible after signing in (director) and Name after signing inVisible after signing in (managing director) resign · KEMPHANEN appointed as managing director · General meeting of 27-06-2018 · Gazette deed
Absorbed by Kemphanenmerger by absorption, May 2021
Activity
“Het oprichten, overnemen en uitbaten van apotheken, aankoop en verkoop, in- en uitvoer, fabricatie…” (deed in Dutch)From the articles, 5 activitiesNo NACE code in the KBO
MARKTAPOTHEEK had an average of 1.2 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of MARKTAPOTHEEK?
The turnover in financial year 2020 is ≈ €460,000. This figure is estimated from the gross margin of €178,290 and 1,393 comparable companies of the same size. It probably lies between €280,000 and €860,000. It is a rough estimate.
Is MARKTAPOTHEEK profitable?
In financial year 2020, MARKTAPOTHEEK made a profit of €126,666.
Where can I find the annual accounts of MARKTAPOTHEEK?
MARKTAPOTHEEK filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2020.